Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study
Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Immune checkpoint inhibitors (ICI) produce durable antitumor responses but provoke autoimmune toxicities, including uncommon but potentially devastating neurologic toxicities. The clinical features, including the spectrum, timing, and outcomes, of ICI-induced neurologic toxicities are not well characterized.
We performed disproportionality analy...
Alternative Titles
Full title
Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_8a49fe1ef8604ebfb6673277f8b07034
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8a49fe1ef8604ebfb6673277f8b07034
Other Identifiers
ISSN
2051-1426
E-ISSN
2051-1426
DOI
10.1186/s40425-019-0617-x
